Sars Spike Protein Antibody
Lab Reagents
Human IgG antibody Laboratories manufactures the sars spike protein antibody reagents distributed by Genprice. The Sars Spike Protein Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Sars products are available in stock. Specificity: Sars Category: Spike Group: Protein Antibody
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit |
|||
Spike-192V | Creative BioMart | 100ug | EUR 950.4 |
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Human IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit |
|||
Spike-193V | Creative BioMart | 100ug | EUR 1932 |
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
SARS (IN1) Spike Peptide |
|||
3221P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN1) Spike peptide |
SARS (IN2) Spike Peptide |
|||
3223P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN2) Spike peptide |
SARS (IN3) Spike Peptide |
|||
3225P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN3) Spike peptide |
Recombinant 2019-nCoV coronavirus Spike protein, S1+S2 ECD |
|||
Spike-194V | Creative BioMart | 100ug | EUR 1932 |
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S1+S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cell. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS Biotinylated Spike RBD Recombinant Protein |
|||
10-212 | ProSci | 0.1 mg | EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Sars-Cov, Spike (Middle) Recom Protein |
|||
abx060656-1mg | Abbexa | 1 mg | EUR 2030.4 |
SARS Associated Spike Mosaic S Protein |
|||
20-abx260156 | Abbexa |
|
|
Recombinant SARS Spike gp C Protein |
|||
VAng-Lsx0072-inquire | Creative Biolabs | inquire | Ask for price |
Description: SARS Spike glycoprotein C, recombinant protein from E. coli. |
SARS-CoV-2 Spike Monoclonal Antibody |
|||
A73664-050 | EpiGentek | 50 ul | EUR 341 |
SARS-CoV-2 Spike Monoclonal Antibody |
|||
A73664-100 | EpiGentek | 100 ul | EUR 518.1 |
SARS-CoV-2 Spike Monoclonal Antibody |
|||
A73664 | EpiGentek |
|
|
Recombinant 2019-nCoV coronavirus Spike protein S1 subunit receptor binding domain |
|||
Spike-19V | Creative BioMart | 100ug | EUR 950.4 |
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit receptor binding domain (RBD) was fused to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. |
SARS-CoV-2 Spike Peptide |
|||
9083P | ProSci | 0.05 mg | EUR 235.5 |
Description: (NT) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Spike Peptide |
|||
9087P | ProSci | 0.05 mg | EUR 235.5 |
Description: (CT) SARS-CoV-2 Spike RBD peptide |
SARS-CoV-2 Spike Peptide |
|||
9091P | ProSci | 0.05 mg | EUR 235.5 |
Description: (IN) SARS-CoV-2 Spike peptide |